Elgethun Capital Management’s Boston Scientific BSX Stock Holding History

Elgethun Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,485	Closed	-$305K	–	98
2019 Q3	$305K	Hold	7,485	–	–	0.16%	71
2019 Q2	$322K	Hold	7,485	–	–	0.18%	70
2019 Q1	$287K	Hold	7,485	–	–	0.17%	75
2018 Q4	$258K	Hold	7,485	–	–	0.18%	78
2018 Q3	$292K	Hold	7,485	–	–	0.19%	73
2018 Q2	$245K	Hold	7,485	–	–	0.17%	77
2018 Q1	$204K	Buy	+7,485	New	+$203K	0.14%	91
2017 Q4	–	Sell	-7,485	Closed	-$218K	–	94
2017 Q3	$218K	Hold	7,485	–	–	0.16%	80
2017 Q2	$207K	Buy	+7,485	New	+$199K	0.16%	78
2017 Q1	–	Sell	-7,485	Closed	-$162K	–	94
2016 Q4	$162K	Buy	+7,485	New	+$163K	0.13%	82

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Elgethun Capital Management's BSX Position: Q4 2019 in Review

Elgethun Capital Management sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 7,485 shares — an estimated $305K sold.

Elgethun Capital Management first reported a position in BSX in Q4 2016 and held it in 10 quarters. The position peaked at $322K in Q2 2019. 854 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

Elgethun Capital Management reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
Elgethun Capital Management sold 7,485 Boston Scientific shares in Q4 2019, an estimated $305K.
Elgethun Capital Management first reported a position in Boston Scientific in Q4 2016 and held it in 10 quarters.
Elgethun Capital Management's Boston Scientific position peaked at $322K in Q2 2019.
854 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Elgethun Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.